Interval cancers in the beginning years of the breast cancer screening programme in the Belgian province of Limburg

被引:4
作者
Kellen, E. [1 ]
Putte, G. Vande [1 ]
Van Steen, A. [1 ,2 ]
Cloes, E.
Lousbergh, D.
Buntinx, F. [3 ]
Van Limbergen, E. [1 ]
机构
[1] Katholieke Univ Leuven, Ctr Canc Prevent LUCK, Louvain, Belgium
[2] Univ Hosp KU Leuven, Dept Radiol, Louvain, Belgium
[3] Katholieke Univ Leuven, Dept Gen Practice, Louvain, Belgium
关键词
breast cancer; screening; interval cancer;
D O I
10.1179/acb.2008.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the occurrence of interval breast cancers among those women who attended the mammography screening programme in the Belgian province of Limburg. Interval cancers are tumours that are being diagnosed before the next scheduled screening round and are related to the sensitivity and the screening interval. Methods Biennial screening is provided to all women aged 50-69. The records of the screening programme were linked to those of the cancer registry. The interval cancer rate, expressed as a proportion of the underlying (expected) breast cancer incidence rate was calculated. The observed interval cancer incidence is the number of interval cancers per 10,000 'negative' screening tests. Results The interval cancer rate in the first year was 25.37% for all cancers (ductal carcinoma in situ included) and 21.7% when the analysis was restricted to invasive tumours. Proportional incidence of interval cancer in the second year after screening was 12.02% for all cancers. Conclusion In conclusion, the interval cancer rates in the Belgian province of Limburg were compatible with the European guidelines. However, increasing the recall rate in our programme and systematically reviewing the interval cancers may improve the quality of the programme even further.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 20 条
[1]  
Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473
[2]  
[Anonymous], 2006, EUR GUID QUAL ASS BR
[3]   Breast cancer incidence and mortality trends in 16 European countries [J].
Botha, JL ;
Bray, F ;
Sankila, R ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) :1718-1729
[4]   Comparison of early performance indicators for screening projects within the European Breast Cancer Network:: 1989-2000 [J].
Broeders, MJM ;
Scharpantgen, A ;
Ascunce, N ;
Gairard, B ;
Olsen, AH ;
Mantellini, P ;
Mota, TC ;
Van Limbergen, E ;
Séradour, B ;
Ponti, A ;
Trejo, LS ;
Nyström, L .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (02) :107-116
[5]   Methodological issues in international comparison of interval breast cancers [J].
Bulliard, Jean-Luc ;
Sasieni, Peter ;
Klabunde, Carrie ;
De Landtsheer, Jean-Pierre ;
Yankaskas, Bonnie C. ;
Fracheboud, Jacques .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) :1158-1163
[6]   A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors [J].
Collett, K ;
Stefansson, IM ;
Eide, J ;
Braaten, A ;
Wang, H ;
Eide, GE ;
Thoresen, SO ;
Foulkes, WD ;
Akslen, LA .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) :1108-1112
[7]   High expression of the trefoil protein TFF1 in interval breast cancers [J].
Crosier, M ;
Scott, D ;
Wilson, RG ;
Griffiths, CDM ;
May, FEB ;
Westley, BR .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :215-221
[8]  
DEGAUQUIER K, 2007, ARCH PUBLIC IN PRESS
[9]   Biologic characteristics of interval and screen-detected breast cancers [J].
Gilliland, FD ;
Joste, N ;
Stauber, PM ;
Hunt, WC ;
Rosenberg, R ;
Redlich, G ;
Key, CR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (09) :743-749
[10]   Screening for breast cancer with mammography [J].
Gotzsche, P. C. ;
Nielsen, M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04)